(azithromycin dihydrate TABLET, SUSPENSION)
ZITHROMAX is supplied in the following strengths and package configurations:
| Tablet strength | Tablet Color/Shape | Tablet Markings | Package Size | NDC Code |
|---|---|---|---|---|
250 mg | Pink modified capsular shaped, engraved, film-coated | Engraved with "PFIZER" on one side and "306" on the other | Bottles of 30 | NDC 0069-3060-30 |
Boxes of 3 (Z-PAKS® of 6) | NDC 0069-3060-75 | |||
Unit Dose package of 50 | NDC 0069-3060-86 | |||
Engraved with "Pfizer" on one side and "ZTM 250" on the other | Bottles of 30 | NDC 0069-4061-01 | ||
Boxes of 3 (Z-PAKS® of 6) | NDC 0069-4061-75 | |||
Unit Dose package of 50 | NDC 0069-4061-89 | |||
500 mg | Pink modified capsular shaped, engraved, film coated | Engraved with "Pfizer" on one side and "ZTM500" on the other | Bottles of 30 | NDC 0069-3070-30 |
Boxes of 3 (TRI-PAKS™ of 3 tablets) | NDC 0069-3070-75 |
ZITHROMAX tablets should be stored between 15° to 30°C (59° to 86°F).
ZITHROMAX for oral suspension after constitution contains a flavored suspension. ZITHROMAX for oral suspension is supplied to provide 100 mg/5 mL or 200 mg/5 mL suspension in bottles as follows:
| Azithromycin contents per bottle | NDC |
|---|---|
300 mg | 0069-3110-19 |
600 mg | 0069-3120-19 |
900 mg | 0069-3130-19 |
1200 mg | 0069-3140-19 |
[see Dosage and Administration (2)] for constitution instructions with each bottle type.
{{section_name_patient}}
{{section_body_html_patient}}
Additional Resources
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine or vaccine.
Speak with a Pfizer Medical Information Professional regarding your Pfizer medicine or vaccine inquiry.
Available 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for a Pfizer medicine or a vaccine.
The submission will be reviewed during our standard business hours.
To report an adverse event related to a Pfizer product and you are not part of a clinical trial* for this medication, click the link below to submit your information:
Pfizer Safety Reporting Site
*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.
If you cannot use the above website to report an adverse event related to a Pfizer medication, please call (800) 438-1985.
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or by calling (800) 332-1088.